Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Precigen Inc (NQ: PGEN )

1.410 +0.070 (+5.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 606,639
Open 1.350
Bid (Size) 1.280 (1)
Ask (Size) 1.460 (50)
Prev. Close 1.340
Today's Range 1.310 - 1.410
52wk Range 1.120 - 6.455
Shares Outstanding 206,643,428
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was... 
Via Benzinga

Performance

YTD
-64.57%
-64.57%
1 Month
+12.80%
+12.80%
3 Month
-44.27%
-44.27%
6 Month
-64.57%
-64.57%
1 Year
-77.48%
-77.48%

More News

Read More
Recap: Precigen Q4 Earnings
Via Benzinga
Earnings Scheduled For March 1, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
PRECIGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Precigen, Inc. f/k/a Intrexon Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Via Benzinga
Exposures Product Safety
Looking Into Precigen's Return On Capital Employed
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
3 Synthetic Biology Stocks In Focus With Strong Potential
Via Talk Markets
Precigen Reveals Early Data From CAR-T Candidate In Blood Cancer Patients
Via Benzinga
5 Penny Stocks Insiders Are Buying
Via Benzinga
5 Penny Stocks Insiders Are Buying
Via Benzinga
Precigen Posts Additional Interim Data From Type 1 Diabetes Trial
Via Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
Via Benzinga
Exposures Product Safety
Precigen Earnings Perspective: Return On Capital Employed
Via Benzinga
Precigen, inc (PGEN) Q2 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Precigen: Q2 Earnings Insights
Via Benzinga
Precigen Insights: Return On Capital Employed
Via Benzinga
Earnings Scheduled For August 9, 2021
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.